Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cytokeratin 5 Antikörper

Dieses Anti-Cytokeratin 5-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von Cytokeratin 5 in IHC und ELISA. Geeignet für Human. Dieses Primary Antibody wurde in 2+ Publikationen zitiert.
Produktnummer ABIN969078

Kurzübersicht für Cytokeratin 5 Antikörper (ABIN969078)

Target

Alle Cytokeratin 5 (KRT5) Antikörper anzeigen
Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))

Reaktivität

  • 148
  • 85
  • 57
  • 12
  • 11
  • 11
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 108
  • 54
  • 2
Maus

Klonalität

  • 93
  • 71
Monoklonal

Konjugat

  • 74
  • 17
  • 12
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Cytokeratin 5 Antikörper ist unkonjugiert

Applikation

  • 102
  • 77
  • 47
  • 32
  • 30
  • 27
  • 18
  • 14
  • 13
  • 13
  • 10
  • 9
  • 6
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (IHC), ELISA

Klon

3E2F1
  • Verwendungszweck

    Cytokeratin 5 Antibody

    Aufreinigung

    Ascitic fluid

    Immunogen

    Purified recombinant fragment of CK5 expressed in E. Coli.

    Isotyp

    IgG1
  • Applikationshinweise

    ELISA: 1/10000

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Ascitic fluid containing 0.03 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Canedo-Patzi, León-Bojorge, de Ortíz-Hidalgo: "[Adenomatoid tumor of the genital tract. Clinical, pathological and immunohistochemical study in 9 cases]." in: Gaceta médica de México, Vol. 142, Issue 1, pp. 59-66, (2006) (PubMed).

    Leibl, Moinfar: "Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation." in: The American journal of surgical pathology, Vol. 30, Issue 4, pp. 450-6, (2006) (PubMed).

  • Target

    Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))

    Andere Bezeichnung

    Cytokeratin 5

    Hintergrund

    CK5 (keratin 5) is a member of the keratin gene family. Biochemically, most members of the CK family fall into one of two classes, type I (acidic polypeptides) and type II (basic polypeptides). The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. The type II cytokeratins are clustered in a region of chromosome 12q12-q13. At least one member of the acidic family and one member of the basic family is expressed in all epithelial cells. Cytokeratin 5 is expressed in normal basal cells. Mutations of the Cytokeratin5 gene (KRT5) have been shown to result in the autosomal dominant disorderepidermolysis bullosa (EB). Defects in KRT5 are a cause of epidermolysis bullosa simplex.

    Gen-ID

    3852

    UniProt

    P13647
Sie sind hier:
Chat with us!